申请人:MERRELL DOW PHARMACEUTICALS INC.
公开号:EP0348891A2
公开(公告)日:1990-01-03
Use of certain known lactamimide derivatives for the preparation of a pharmaceutical composition with valuable calcium channel blocking activity. By virtue of the calcium antagonistic activity of these compounds the pharmaceutical compositions are antihypertensives and will have other activities associated with calcium antagonists.
利用某些已知的内酰胺类衍
生物制备具有重要
钙通道阻断活性的药物组合物。凭借这些化合物的
钙拮抗剂活性,药物组合物具有降压作用,并具有与
钙拮抗剂相关的其他活性。